4ACE11AC-A2EE-4B21-808F-4BB5BEEC4200A Chemical Technology to Generate Homogeneous Antibody-Drug-Conjugates (ADCs) and BispecificsResearch GrantBB/L024349/12512EF1C-401B-4222-9869-A770D4C5FAC7BBSRCINCOME_ACTUAL4800856CA4F796-1035-49CC-A57A-1B9529EE1292Pyridazinediones deliver potent, stable, targeted and efficacious antibody-drug conjugates (ADCs) with a controlled loading of 4 drugs per antibodyRSC Advancesfe29cc661306d654b9abacc95dc33baeRobinson E2017-01-01http://dx.doi.org/10.1039/c7ra00788dhttp://dx.doi.org/10.1039/c7ra00788d15Journal Article/Review58beaa507c5c30.62158875